health

More +
Roche therapy helps 24 percent of untreated bladder cancer patients study

Roche therapy helps 24 percent of untreated bladder cancer patients study

A newly approved immunotherapy from Roche Holding proved effective as an initial treatment for some ... Read More
Sanofi Regeneron Dupilumab trial positive

Sanofi Regeneron Dupilumab trial positive

PARIS-- French drug giant Sanofi SAN.FR and U.S. partner Regeneron Pharmaceuticals REGN -1.57% said ... Read More
Atezolizumab for Bladder Cancer Provocative Overall Survival

Atezolizumab for Bladder Cancer Provocative Overall Survival

CHICAGO - The anti-PD-L1 immunotherapy atezolizumab Tecentriq Genentech which recently made headline... Read More

Durand Hotels

More +